- ICH GCP
- 미국 임상 시험 레지스트리
- 임상시험 NCT07575399
Efficacy, Safety and Tolerability of Switching From Glucagon-like Peptide-1 Receptor Agonists (GLP-1RA) to Maridebart Cafraglutide in Adults With Obesity or Overweight (MARITIME-SWITCH)
A Phase 3, Open-label Trial to Evaluate the Efficacy, Safety and Tolerability of Switching From the Glucagon-like Peptide-1 Receptor Agonists to Maridebart Cafraglutide in Adult Participants With Obesity or Overweight
Efficacy, safety and tolerability of switching from GLP-1RA to maridebart cafraglutide in adults with obesity or overweight.
연구 개요
연구 유형
등록 (추정된)
단계
- 3단계
연락처 및 위치
연구 연락처
- 이름: Amgen Call Center
- 전화번호: 866-572-6436
- 이메일: medinfo@amgen.com
연구 장소
-
-
Alabama
-
Pelham, Alabama, 미국, 35124
- 모병
- Cahaba Research, Inc.
-
-
Arizona
-
Chandler, Arizona, 미국, 85224
- 모병
- Arizona Clinical Trials
-
Sun City, Arizona, 미국, 85351
- 모병
- Epic Medical Research - Sun City
-
Sun City West, Arizona, 미국, 85375
- 모병
- Clinical Research Institute of Arizona LLC
-
-
California
-
Chula Vista, California, 미국, 91911
- 모병
- Peninsula Research Associates
-
Palm Springs, California, 미국, 92262
- 모병
- Desert Oasis Healthcare Medical Group
-
Rialto, California, 미국, 92377
- 모병
- Inland Empire Liver Foundation
-
San Diego, California, 미국, 92120
- 모병
- Apex Clinical Research
-
Santa Ana, California, 미국, 92701
- 모병
- Southern California Clinical Research
-
-
Florida
-
Gainesville, Florida, 미국, 32610
- 모병
- University of Florida Department of Medicine
-
Hialeah, Florida, 미국, 33012
- 모병
- Aga Clinical Trials
-
Margate, Florida, 미국, 33063
- 모병
- South Florida Clinical Research
-
Miami, Florida, 미국, 33165
- 모병
- New Horizon Research Center
-
Miami, Florida, 미국, 33173
- 종료됨
- Research Institute of South Florida
-
Mt. Dora, Florida, 미국, 32757
- 모병
- Adult Medicine of Lake County
-
Orlando, Florida, 미국, 32825
- 모병
- Florida Institute for Clinical Research
-
Orlando, Florida, 미국, 32801
- 종료됨
- Clinical Neuroscience Solutions
-
Port Orange, Florida, 미국, 32127
- 모병
- Progressive Medical Research
-
The Villages, Florida, 미국, 32162
- 모병
- Charter Research - The Villages
-
-
Georgia
-
Canton, Georgia, 미국, 30114
- 모병
- East Coast Institute for Research
-
Columbus, Georgia, 미국, 31904
- 모병
- Columbus Research Foundation
-
Johns Creek, Georgia, 미국, 30024
- 모병
- Nsc Research
-
Union City, Georgia, 미국, 30291
- 모병
- Rophe Adult and Pediatric Medicine/Sky Clinical Research Network Group
-
Woodstock, Georgia, 미국, 30189
- 모병
- North Georgia Clinical Research
-
-
Hawaii
-
Kapolei, Hawaii, 미국, 96707
- 모병
- Mel A. Ona, M.D., Incorporated
-
-
Idaho
-
Meridian, Idaho, 미국, 83646
- 모병
- Solaris Clinical Research
-
-
Illinois
-
Skokie, Illinois, 미국, 60077
- 모병
- Endeavor Health
-
Springfield, Illinois, 미국, 62704
- 모병
- Central Illinois Diabetes and Clinical Research, a Division of Prairie Education and Research Cooper
-
-
Kansas
-
Lenexa, Kansas, 미국, 66219
- 모병
- Johnson County Clinical Trials
-
-
Louisiana
-
Baton Rouge, Louisiana, 미국, 70808
- 모병
- Pennington Biomedical Research Center
-
-
Michigan
-
Southfield, Michigan, 미국, 48034
- 모병
- Great Lakes Research Institute
-
Troy, Michigan, 미국, 48098
- 모병
- Arcturus Healthcare, Public Limited Company, Troy Internal Medicine Research Division
-
-
Mississippi
-
Ridgeland, Mississippi, 미국, 39157
- 모병
- Sky Integrative Medical Center
-
-
Montana
-
Missoula, Montana, 미국, 59808
- 모병
- Montana Medical Research
-
-
Nevada
-
Las Vegas, Nevada, 미국, 89109
- 모병
- Excel Clinical Research
-
-
New York
-
New York, New York, 미국, 10029
- 모병
- Icahn School of Medicine at Mount Sinai
-
Rochester, New York, 미국, 14609
- 모병
- Rochester Clinical Research
-
-
North Carolina
-
Morehead City, North Carolina, 미국, 28557
- 모병
- Centricity Research Morehead City Specialty
-
Raleigh, North Carolina, 미국, 27609
- 모병
- Accellacare of Raleigh
-
Wilmington, North Carolina, 미국, 28401
- 모병
- Accellacare Research of Wilmington
-
-
Oklahoma
-
Chickasha, Oklahoma, 미국, 73018
- 모병
- Epic Medical Research - Oklahoma
-
Oklahoma City, Oklahoma, 미국, 73112
- 모병
- Lynn Health Science Institute
-
-
Pennsylvania
-
Beaver, Pennsylvania, 미국, 15009
- 모병
- Heritage Valley Multispecialty Group Inc
-
Duncansville, Pennsylvania, 미국, 16635
- 모병
- Altoona Center for Clinical Research
-
-
Texas
-
Austin, Texas, 미국, 78757
- 모병
- Pinnacle Clinical Research Georgetown
-
DeSoto, Texas, 미국, 75115
- 모병
- Epic Medical Research - DeSoto
-
Edinburg, Texas, 미국, 78539
- 종료됨
- South Texas Research Institute
-
Houston, Texas, 미국, 77043
- 모병
- Biopharma Informatic, LLC
-
Houston, Texas, 미국, 77089
- 모병
- Research Physicians Network, LLC
-
Houston, Texas, 미국, 77040
- 모병
- JCCT- Juno Northwest Houston
-
McAllen, Texas, 미국, 78503
- 모병
- Biopharma Informatic-McAllen
-
McKinney, Texas, 미국, 75071
- 모병
- Texas Institute of Cardiology
-
North Richland Hills, Texas, 미국, 76180
- 모병
- North Hills Medical Research
-
San Antonio, Texas, 미국, 78215
- 모병
- American Research Corporation
-
San Antonio, Texas, 미국, 78230
- 모병
- VIP Trials
-
San Antonio, Texas, 미국, 78229
- 모병
- Gastroenterology Clinic of San Antonio PA
-
Tomball, Texas, 미국, 77375
- 모병
- Northwest Houston Heart Center
-
-
Washington
-
Redmond, Washington, 미국, 98052
- 모병
- Eastside Research Associates Health Research
-
-
-
-
-
Ponce, 푸에르토 리코, 00717
- 모병
- Puerto Rico Medical Research Inc.
-
-
참여기준
자격 기준
공부할 수 있는 나이
건강한 자원 봉사자를 받아들입니다
연구 대상 성별
설명
Inclusion Criteria:
- Body Mass Index (BMI) ≥ 25 at screening.
- Weight loss of ≥ 10% on weekly GLP-1 RA.
- Stable body weight.
- Stable dose of GLP-1RA.
- Stable gastrointestinal (GI) tolerability.
- Contraception for females.
- Willingness to follow trial procedures for the duration of the trial.
Exclusion Criteria:
- Obesity induced by other endocrine disorders (ex: Cushing's syndrome).
- Previous or planned surgical, endoscopic or device-based treatment for obesity.
- History of malignancy.
- Type 1/Type 2 diabetes mellitus (DM).
- Family or personal history of medullary thyroid cancer.
- Previous participation in a Maridebart Cafraglutide trial.
공부 계획
연구는 어떻게 설계됩니까?
디자인 세부사항
- 주 목적: 치료
- 할당: 무작위
- 중재 모델: 병렬 할당
- 마스킹: 더블
무기와 개입
참가자 그룹 / 팔 |
개입 / 치료 |
|---|---|
|
실험적: MariTide Arm 1
Participants will receive maridebart cafraglutide dosing schedule 1 during the treatment period. |
Maridebart cafraglutide will be administered via subcutaneous (SC) injection.
다른 이름들:
|
|
실험적: MariTide Arm 2
Participants will receive maridebart cafraglutide dosing schedule 2 during the treatment period. |
Maridebart cafraglutide will be administered via subcutaneous (SC) injection.
다른 이름들:
|
연구는 무엇을 측정합니까?
주요 결과 측정
결과 측정 |
기간 |
|---|---|
|
Percent Change from Baseline in Body Weight at Week 68
기간: Week 68
|
Week 68
|
2차 결과 측정
결과 측정 |
기간 |
|---|---|
|
Percent Change in Body Weight Prior to the Start of Weekly GLP-1RA at Week 68
기간: Week 68
|
Week 68
|
|
Percentage of Participants Maintaining ≥ 80% of the Body Weight Reduction Achieved with Prior Weekly GLP-1RA Treatment at Week 68
기간: Week 68
|
Week 68
|
|
Percent Maintenance of the Body Weight Reduction Achieved with Prior Weekly GLP-1RA Treatment at Week 68
기간: Week 68
|
Week 68
|
|
Plasma Concentration of Maridebart Cafraglutide at Week 68
기간: Week 68
|
Week 68
|
|
Number of Participants with Treatment-emergent Adverse Events and Serious Adverse Events
기간: Up to 84 weeks
|
Up to 84 weeks
|
공동 작업자 및 조사자
스폰서
수사관
- 연구 책임자: MD, Amgen
간행물 및 유용한 링크
연구 기록 날짜
연구 주요 날짜
연구 시작 (실제)
기본 완료 (추정된)
연구 완료 (추정된)
연구 등록 날짜
최초 제출
QC 기준을 충족하는 최초 제출
처음 게시됨 (실제)
연구 기록 업데이트
마지막 업데이트 게시됨 (실제)
QC 기준을 충족하는 마지막 업데이트 제출
마지막으로 확인됨
추가 정보
이 연구와 관련된 용어
추가 관련 MeSH 약관
기타 연구 ID 번호
- 20250036
개별 참가자 데이터(IPD) 계획
개별 참가자 데이터(IPD)를 공유할 계획입니까?
IPD 계획 설명
De-identified individual patient data for variables necessary to address the specific research question in an approved data sharing request.
IPD 공유 기간
Data sharing requests relating to this trial will be considered beginning 18 months after the trial has ended and either 1) the product and indication (or other new use) have been granted marketing authorization in both the US and Europe, or 2) clinical development for the product and/or indication discontinues and the data will not be submitted to regulatory authorities. There is no end date for eligibility to submit a data sharing request for this trial.
IPD 공유 액세스 기준
Qualified researchers may submit a request containing the research objectives, the Amgen product(s) and Amgen trial/trials in scope, endpoints/outcomes of interest, statistical analysis plan, data requirements, publication plan, and qualifications of the researcher(s). In general, Amgen does not grant external requests for individual patient data for the purpose of re-evaluating safety and efficacy issues already addressed in the product labelling. Requests are reviewed by a committee of internal advisors, and if not approved, may be further arbitrated by a Data Sharing Independent Review Panel. Upon approval, information necessary to address the research question will be provided under the terms of a data sharing agreement. This may include anonymized individual patient data and/or available supporting documents, containing fragments of analysis code where provided in analysis specifications. Further details are available at the URL below.
IPD 공유 지원 정보 유형
- 연구_프로토콜
- 수액
- ICF
- CSR
약물 및 장치 정보, 연구 문서
미국 FDA 규제 의약품 연구
미국 FDA 규제 기기 제품 연구
이 정보는 변경 없이 clinicaltrials.gov 웹사이트에서 직접 가져온 것입니다. 귀하의 연구 세부 정보를 변경, 제거 또는 업데이트하도록 요청하는 경우 register@clinicaltrials.gov. 문의하십시오. 변경 사항이 clinicaltrials.gov에 구현되는 즉시 저희 웹사이트에도 자동으로 업데이트됩니다. .